These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 21411605)

  • 41. [Seroprevalence of Lyme borreliosis in workers from Cordoba, Colombia].
    Miranda J; Mattar S; Perdomo K; Palencia L
    Rev Salud Publica (Bogota); 2009; 11(3):480-9. PubMed ID: 20027520
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of serologic tests for the detection of serum antibodies to whole-cell and recombinant Borrelia burgdorferi antigens in cattle.
    Magnarelli LA; Bushmich SL; Sherman BA; Fikrig E
    Can Vet J; 2004 Aug; 45(8):667-73. PubMed ID: 15368740
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of recombinant OspA in two different Borrelia vaccines with respect to immunological response and its relationship to functional parameters.
    Grosenbaugh DA; De Luca K; Durand PY; Feilmeier B; DeWitt K; Sigoillot-Claude C; Sajous ML; Day MJ; David F
    BMC Vet Res; 2018 Oct; 14(1):312. PubMed ID: 30326885
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of whole-cell antibodies and an antigenic flagellar epitope of Borrelia burgdorferi in serologic tests for diagnosis of Lyme borreliosis.
    Magnarelli LA; Fikrig E; Berland R; Anderson JF; Flavell RA
    J Clin Microbiol; 1992 Dec; 30(12):3158-62. PubMed ID: 1280650
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibodies to Borrelia turicatae in Experimentally Infected Dogs Cross-React with Borrelia burgdorferi Serologic Assays.
    Gettings JR; Lopez JE; Krishnavahjala A; Armstrong BA; Thompson AT; Yabsley MJ
    J Clin Microbiol; 2019 Sep; 57(9):. PubMed ID: 31270181
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Borrelia miyamotoi infection leads to cross-reactive antibodies to the C6 peptide in mice and men.
    Koetsveld J; Platonov AE; Kuleshov K; Wagemakers A; Hoornstra D; Ang W; Szekeres S; van Duijvendijk GLA; Fikrig E; Embers ME; Sprong H; Hovius JW
    Clin Microbiol Infect; 2020 Apr; 26(4):513.e1-513.e6. PubMed ID: 31404672
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Antibodies and T-cell reactivity to Borrelia burgdorferi in an asymptomatic population: a study of healthy blood donors in an inland town district in the south-east of Sweden.
    Ekerfelt C; Masreliez C; Svenvik M; Ernerudh J; Roberg M; Forsberg P
    Scand J Infect Dis; 2001; 33(11):806-8. PubMed ID: 11760157
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Identification of Surface Epitopes Associated with Protection against Highly Immune-Evasive VlsE-Expressing Lyme Disease Spirochetes.
    Batool M; Caoili SEC; Dangott LJ; Gerasimov E; Ionov Y; Piontkivska H; Zelikovsky A; Waghela SD; Rogovskyy AS
    Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29866906
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human Lyme arthritis and the immunoglobulin G antibody response to the 37-kilodalton arthritis-related protein of Borrelia burgdorferi.
    Salazar CA; Rothemich M; Drouin EE; Glickstein L; Steere AC
    Infect Immun; 2005 May; 73(5):2951-7. PubMed ID: 15845501
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Linear B Cell Epitopes Derived from the Multifunctional Surface Lipoprotein BBK32 as Targets for the Serodiagnosis of Lyme Disease.
    Toumanios C; Prisco L; Dattwyler RJ; Arnaboldi PM
    mSphere; 2019 May; 4(3):. PubMed ID: 31043513
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prospective study of serologic tests for lyme disease.
    Steere AC; McHugh G; Damle N; Sikand VK
    Clin Infect Dis; 2008 Jul; 47(2):188-95. PubMed ID: 18532885
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Use of recombinant antigens of Borrelia burgdorferi in serologic tests for diagnosis of lyme borreliosis.
    Magnarelli LA; Fikrig E; Padula SJ; Anderson JF; Flavell RA
    J Clin Microbiol; 1996 Feb; 34(2):237-40. PubMed ID: 8788993
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Persistence of the antibody response to the VlsE sixth invariant region (IR6) peptide of Borrelia burgdorferi after successful antibiotic treatment of Lyme disease.
    Peltomaa M; McHugh G; Steere AC
    J Infect Dis; 2003 Apr; 187(8):1178-86. PubMed ID: 12695996
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Analysis of Borrelia burgdorferi genostrains among patients with Lyme disease].
    Biesiada G; Czepiel J; Salamon D; Garlicki A; Dziubek A; Maziarz B; Mach T
    Przegl Lek; 2009; 66(9):511-2. PubMed ID: 21033412
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Diagnostic value of proteins of three Borrelia species (Borrelia burgdorferi sensu lato) and implications for development and use of recombinant antigens for serodiagnosis of Lyme borreliosis in Europe.
    Hauser U; Lehnert G; Wilske B
    Clin Diagn Lab Immunol; 1998 Jul; 5(4):456-62. PubMed ID: 9665948
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Our experience with examination of antibodies against antigens of Borrelia burgdorferi in patients with suspected lyme disease.
    Durovska J; Bazovska S; Ondrisova M; Pancak J
    Bratisl Lek Listy; 2010; 111(3):153-5. PubMed ID: 20437826
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Variable serum immunoglobulin responses against different Borrelia burgdorferi sensu lato species in a population at risk for and patients with Lyme disease.
    Bunikis J; Olsén B; Westman G; Bergstroöm S
    J Clin Microbiol; 1995 Jun; 33(6):1473-8. PubMed ID: 7650170
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Development of a multiplex assay for the detection of antibodies to Borrelia burgdorferi in horses and its validation using Bayesian and conventional statistical methods.
    Wagner B; Freer H; Rollins A; Erb HN; Lu Z; Gröhn Y
    Vet Immunol Immunopathol; 2011 Dec; 144(3-4):374-81. PubMed ID: 21890217
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clonal diversification in OspA-specific antibodies from peripheral circulation of a chronic Lyme arthritis patient.
    Ghosh S; Huber BT
    J Immunol Methods; 2007 Apr; 321(1-2):121-34. PubMed ID: 17307198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Pre-treatment and post-treatment assessment of the C(6) test in patients with persistent symptoms and a history of Lyme borreliosis.
    Fleming RV; Marques AR; Klempner MS; Schmid CH; Dally LG; Martin DS; Philipp MT
    Eur J Clin Microbiol Infect Dis; 2004 Aug; 23(8):615-8. PubMed ID: 15243815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.